Vedanta Oil and Gas Ltd (VOGL) Q1 FY27 Results Analysis: EBITDA Margin Expands 1060 bps, Production Slips 17% QoQ

CompoundingAI Research Updated July 29, 2026 2 min read
Neutral

Vedanta Oil and Gas Ltd's Q1 FY27 numbers came in mixed, with revenue of Rs. 2,507.00 Cr (+8.50% YoY) and PAT growth of +1009.00% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateJuly 29, 2026
QuarterQ1 FY 2026-2027
Revenue (Q1)Rs. 2,507.00 Cr (+8.50% YoY)
PAT (Q1)Rs. 945.00 Cr (+1009.00% YoY)
EBITDA margin32.50% (+1060 bps YoY)
EPS (Q1)Rs. 2.42
Market capRs. 13,690.15 Cr
CMPRs. 35.07

Quarter Snapshot

Revenue grew 8.5% YoY to Rs.2,507 Cr, with EBITDA margin before exceptional improving to 32.5% from 21.9% YoY. However, production declined 17% QoQ to ~77 kboepd, and continuing operations remained loss-making at PAT of Rs.152 Cr after exceptional items. Total PAT turned positive at Rs.945 Cr driven by a one-time gain from discontinued operations. The company faces regulatory risk from the Cambay Block impairment.

Key Investment Insights

Key Positives

  • Revenue grew 8.5% YoY to Rs.2,507 Cr, supported by higher crude realisations.
  • EBITDA margin before exceptional expanded to 32.5% from 21.9% YoY.
  • Total expenses fell 3.5% YoY while revenue grew, demonstrating operating leverage.
  • Finance costs declined 34% YoY to Rs.110 Cr, reflecting lower debt post-demerger.
  • Normalized PAT from continuing operations turned positive at Rs.193 Cr.
  • Total PAT of Rs.945 Cr vs loss of Rs.104 Cr in Q1FY26, driven by discontinued ops gain.

Risk Factors

  • Production declined 17% QoQ to ~77 kboepd from ~93 kboepd in Q4FY26, impacting sequential revenue.
  • Continuing operations reported a PAT loss of Rs.152 Cr after exceptional items.
  • Impairment of Rs.379 Cr on Cambay Block due to regulatory setback from Delhi HC.
  • Other income declined 52.8% YoY to Rs.151 Cr.
  • Promoter encumbrance at 99.99% remains high.
Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.

Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings

Login Now